Medivir appoints Erik Björk as Chief Financial Officer
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces today that it has appointed Erik Björk as Chief Financial Officer effective January 3, 2018. Erik Björk will join Medivir from AstraZeneca where he has been the CFO for Sweden Operations. He has extensive experience as a global financial leader having previously held various financial roles including division CFO, financial planning and controller positions, at Proctor & Gamble in Switzerland, the UK and Sweden. Erik has a MSc in Business and Economics and a Master of Laws both from Lund University. “I am delighted to